Three Quick Facts: British American Tobacco, Oncimmune and Itaconix

8th June 2021
Tony Cross
Three Quick Facts
British American Tobacco, Oncimmune Holdings, Itaconix

Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

British American Tobacco

There’s a first half pre-close trading statement out from British American Tobacco [LON:BATS] this morning. The stand-out headline is an expectation that for the full year, revenue growth will exceed 5%, so come in ahead of the 3-5% guidance which had been given previously. There’s a lot of talk in the note about commitment to ESG which at least when it comes to some elements seems slightly curious for a company involved in this space. Whilst the next-generation product roll out continues, traditional tobacco will presumably dominate for some time yet.

World No Tobacco Day: Do Big Tobacco companies evolve or die?

Oncimmune Holdings

Oncimmune Holdings [LON:ONC] has published its full year trading update today, with full year revenues up eight times from the 2020 figure, although this was very much in line with market expectations. The company is confident over the coming year, with expectations that many of its ImmunoINSIGHTS service contracts can be converted into strategic commercial partnerships, providing the grounds for another step change in revenue growth.

Subscribe for more stories like this, 8am weekdays - for free!
Your email address

Itaconix

Another small cap to round off with a trading update from Itaconix [LON:ITX], a company working on the use of plant-based materials in every day consumer products. Revenues are up 39% over the first five months when compared to last year’s figures, although the note gives little away in terms of outlook. There are some concerns that supply chain disruption around the end of lockdowns could delay some volume, but as a business and a sector, this focus on plant-based products is certainly one which will be watched with interest.

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.